Sagimet Biosciences SGMT
NASDAQ SGMT
$10.89 +0.06 (+0.55%)
At close: Nov 10, 2026 · 4:00 PM EST

Sagimet Biosciences (SGMT) Preferred Stock Liabilities (2022 - 2023)

Updated

Sagimet Biosciences' Preferred Stock Liabilities was $214.62 million in Q2 2023, unchanged from $214.62 million a year earlier and unchanged from the prior quarter.

Analysis

Sagimet Biosciences (SGMT) Preferred Stock Liabilities (2022 - 2023) Analysis & Trends

From Q2 2022 onward, Sagimet Biosciences has reported Preferred Stock Liabilities for 5 quarters.

  • Per Business Quant data, SGMT's Preferred Stock Liabilities in the three quarters before Q2 2023 was $214.62 million (Q1 2023), $214.62 million (Q4 2022) and $214.62 million (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Sagimet Biosciences 569.92 Mn -4.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 214.62 Mn
Mar 31, 2023 214.62 Mn
Dec 31, 2022 214.62 Mn
Sep 30, 2022 214.62 Mn
Jun 30, 2022 214.62 Mn
API Access

Sagimet Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SGMT&period=max&api_key=YOUR_API_KEY